Which companies overlap with Children's & Women's Health Centre of British Columbia's portfolio?

Top competitors by shared drug class: Oregon Health and Science University.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/children-s-women-s-health-centre-of-british-columbia.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Children's & Women's Health Centre of British Columbia — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Children's & Women's Health Centre of British Columbia pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Glucose 25% oral solution	Glucose 25% oral solution	marketed	Carbohydrate supplement		Endocrinology

Therapeutic area mix

Endocrinology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Oregon Health and Science University · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Children's & Women's Health Centre of British Columbia:

Cite this brief

Drug Landscape (2026). Children's & Women's Health Centre of British Columbia — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/children-s-women-s-health-centre-of-british-columbia. Accessed 2026-05-17.